av awave_user | okt 17, 2016 | Legal Press releases
Intervacc is now carrying out a new share issue of 3,624,518 shares with preferential rights for the shareholders. This issue provides the company with approximately SEK 8.3 million. Shareholders of record date October 13, 2016 will receive information from your...
av awave_user | sep 21, 2016 | News
A series of trials have been conducted at the Animal Health Trust, Newmarket, England. The trials were aimed to measure the safety, immunogenicity, efficacy and DIVA (differentiates infected from vaccinated animals) capability of the Strangvac® vaccine. The...